160 filings
Page 4 of 8
6-K
oc1b51bgqukwa hiba
15 Dec 22
Current report (foreign)
8:00am
6-K
l1go12mg9bjx 4fb
8 Dec 22
Immunoprecise Antibodies LTD. 6-K
8:05am
6-K
mdf8paru2q5znx3o
5 Dec 22
The Company to host an earnings conference call via webcast
8:51am
6-K
039dgf4
30 Nov 22
Immunoprecise Antibodies LTD. 6-K
8:08am
6-K
xib0t1p
22 Nov 22
Immunoprecise Antibodies LTD. 6-K
8:04am
6-K
9ll018
17 Nov 22
Current report (foreign)
9:36am
6-K
vmvjuiu
1 Nov 22
Current report (foreign)
7:07pm
6-K
05rrzhs ud
17 Oct 22
Annual General and Special Meeting
7:07am
6-K
r37cj6d5 7gp4
12 Oct 22
Immunoprecise Antibodies LTD. 6-K
8:09am
6-K
s8xjapwxohvw9pi8d4
14 Sep 22
Immunoprecise Antibodies LTD. 6-K
8:31am
6-K
iivpi4 8j
14 Sep 22
Current report (foreign)
8:31am
6-K
0aqb0
14 Sep 22
Immunoprecise Antibodies LTD. 6-K
8:04am
6-K
sa60rnlmuqbocp93 203
8 Sep 22
The Company to host an earnings conference call via webcast
9:14am
6-K
tz6up
29 Aug 22
Immunoprecise Antibodies LTD. 6-K
8:08am
40-F
r007 iqx1by34gx
29 Jul 22
Annual report (Canada)
9:04am
6-K
fukt3s71sc4c59v
29 Jul 22
Immunoprecise Antibodies LTD. 6-K
8:17am
6-K
qr5hmj
26 Jul 22
The Company to host an earnings conference call via webcast
8:12am
6-K
42ci n3dawrkfd
12 Jul 22
Immunoprecise Antibodies LTD. 6-K
8:16am
6-K
3fb2uepx
9 May 22
IPA subsidiary BioStrand receives grant to expand LENSai platform by linking HYFTsâ„¢ with 3D protein structure and function
8:15am
6-K
gheq0
25 Apr 22
Form 51-102F3 MATERIAL CHANGE REPORT
1:13pm